Revenue segments as reported by the company.

Premiums earned, net

Other income

Investment income, net

Direct Contracting revenue

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Net medical claims incurred

Salaries and benefits

General and administrative expenses

Premium deficiency reserve (benefit) expense

Depreciation and amortization

Other expense

Restructuring costs

Impairment of goodwill and other intangible assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Clover Health Investments

Clover Health Investments Corp. provides healthcare insurance services. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. The company was founded on July 17, 2014 and is headquartered in Franklin, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clover Health reports profitable Q1, poised for sustained growth

Clover Health Investments had a strong Q1 performance, expecting full-year profitability and revenue growth. With a focus on operational enhancements, revenue growth, and cost reductions, the company aims to maintain momentum in 2024 amidst industry challenges. Clover's strategic initiatives like share repurchase program and product enhancements position it well for sustained growth and care management excellence.

Clover Health achieves profitability milestone and eyes market expansion

Clover Health's Q2 2024 earnings call reflects a positive trajectory with increased profitability, strong revenue growth, and improved guidance for the full year.
The company's strategic focus on operational efficiency, technology innovation, and market validation positions it well for sustainable growth and market expansion.
While facing challenges in maintaining profitability and implementing technology enhancements, Clover Health has opportunities to capitalize on market interest and drive further growth in the Medicare Advantage sector.

Clover Health reports strong Q3 performance and eyes growth opportunities

Clover Health Investments (CLOV) showcased strong financial performance and strategic investments in growth areas during the Q3 2024 earnings call. The company's focus on membership growth, quality initiatives, and technology enhancements, along with exploring health partnerships, highlights a promising outlook for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clover Health Investments Corp. is a physician enablement technology company that provides Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. Clover Health Investments was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Franklin, TN.

LOS ANGELES--(BUSINESS WIRE)---- $CLOV #investors--The Law Offices of Frank R. Cruz Announces Investigation of Clover Health Investments, Corp. (CLOV, CLOVW) on Behalf of Investors

The Law Offices of Frank R. Cruz Announces Investigation of Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III (CLOV, CLOVW) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $CLOV #CLOV--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Clover Health Investments, Corp.

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Clover Health Investments, Corp. and Encourages Investors with Losses of $100,000 to Contact the Firm

BENSALEM, Pa.--(BUSINESS WIRE)---- $CLOV #CLASSACTION--Offices of Howard Smith Announces Investigation of Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III (CLOV, CLOVW)

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III (CLOV, CLOVW) on Behalf of Investors

The firm also took aim at Chamath Palihapitiya, Clover's billionaire investor. A report from Hindenburg Research on Thursday claimed that Clover Health is currently under active investigation by the Department of Justice, and that the company failed to disclose the investigation to investors before it went public last month.

Clover Health under fire from Hindenburg, the research firm that took down Nikola

Shares of CLOV stock are falling hard on Thursday after short seller Hindenburg Research reported the firm is under investigation by the DOJ. The post CLOV Stock: Why Recent SPAC Merger Clover Health Is Tumbling Today appeared first on InvestorPlace.

CLOV Stock: Why Recent SPAC Merger Clover Health Is Tumbling Today

Atlanta, Georgia--(Newsfile Corp. - February 4, 2021) - Holzer & Holzer, LLC is investigating whether Clover Health Investments, Corp. ("Clover" or the "Company") (NASDAQ: CLOV) complied with federal securities laws. On February 4, 2021, Hindenburg Research published a report stating that it had obtained a copy of a DOJ Civil Investigative Report seeking testimony in connection with an investigation into "whether Clover Health Investment Corporation and/or related entities improperly induced patient referrals for...

SHAREHOLDER ALERT: Investigation of Clover Health Investments Announced by Holzer & Holzer, LLC

Social Capital Hedosophia Holdings Corp. III

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation into potential securities claims on behalf of shareholders of Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III (NASDAQ: CLOV, CLOVW) (NYSE: IPOC, IPOC.WS, IPOC.U) resulting from allegations that Clover Health may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Clover Health securities you may be

BREAKING NEWS: ROSEN, A LEADING LAW FIRM, Encourages Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III Investors with Losses to Inquire About Class Action Investigation – CLOV, CLOVW, IPOC, IPOC.WS, IPOC.U

Hindenburg accused billionaire investor Chamath Palihapitiya of misleading investors when he took the company public through a SPAC last month.

Palihapitiya-backed Clover Health shares fall on critical report by short-seller Hindenburg Research

Clover Health is under investigation by the US Justice Department, short-seller Hindenburg Research claimed in a report about the Medicare insurer and software provider on Thursday. Clover's shares fell as much as 15% following the news. The company went public last month via a $3.7 billion merger with one of Social Capital CEO Chamath Palihapitiya's special-purpose acquisition vehicles.

Chamath Palihapitiya-backed Clover Health tumbles 15% after short-seller Hindenburg Research says it's under investigation by the DOJ

After decades of effort, electronic health records could finally get an upgrade that allows them to work as intended.

5 Reasons to Buy Clover Health Stock Right Now

Romeo Power

TS Innovation Acquisitions Corp.

At $800 billion, Tesla's disruption appears to be largely priced in. But these brand-new SPACs have single-digit billion market caps and massive potential as well.

Ignore Tesla: Here Are 3 Better Stocks

Social Capital Hedosophia Holdings Corp. IV

Social Capital Hedosophia Holdings Corp. V

Social Capital Hedosophia Holdings Corp. VI

Opendoor

Here are the key things to look for when evaluating a premerger blank-check company.

Your Guide to Analyzing SPAC Investments

Why Chamath Palihapitiya Thinks Clover Health Is Like Virgin Galactic

And he explains exactly why he likes this company so much.

Chamath Palihapitiya Divulges the Greatest Growth Opportunity He's Ever Seen

Here's Clover Health's Secret to Winning Over Healthcare Providers

Clover's technology could give it a key advantage.

Why Tiny Clover Health Thinks It Can Beat Huge Insurers

Here's the explanation from Social Capital CEO Chamath Palihapitiya.

SPAC Investing: Why Social Capital Picked Clover Health

Century Casinos

Canoo

International Game Technology

Melco Resorts and Entertainment

Rocket Companies, Inc.

This week, Joe Biden will be inaugurated as the 46th president of the United States. While there concerns about riskier assets, including stocks under $20, heading into Election Day, it's clear markets are at peace with the idea of a Biden presidency.

7 Great Sub-$20 Stocks to Buy After Inauguration Day

This recent SPAC IPO is disrupting the healthcare status quo with insurance technology.

Should You Buy Clover Health Stock?

GoHealth, Inc.

Root

New tech-enhanced insurance companies have been popping up fast and furious over the last year.

Like Lemonade? Here Are 3 Small Insurance Tech Stocks to Add to Your Watchlist

Why Clover Health's Shares Popped 61.4% in December

Clover Health (CLOV) is trading on the Nasdaq Exchange Friday after completing its merger with SPAC Social Capital Hedosophia Holdings. The post Clover Health SPAC Merger: 8 Things to Know About CLOV Stock as It Starts Trading Today appeared first on InvestorPlace.

Clover Health SPAC Merger: 8 Things to Know About CLOV Stock as It Starts Trading Today

News for Clover Health Investments Stock (CLOV)